Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shannon R. Morris"'
Autor:
Brant A. Inman, Raj S. Pruthi, Andrea Kelly, Kristin Orr, Lori Mixson, Elizabeth M. H. Woodson, Matthew I. Milowsky, Shannon R. Morris, Arjun Vasant Balar, Melissa J. Polasek, Marshall R. Posner, Garrett Nichols
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundPVSRIPO, a novel intratumoral viral immunotherapy, infects cells via CD155, which is widely expressed on solid tumors and antigen-presenting cells (APC). Infection is lethal in malignant cells, but a unique, activating, nonlethal infection
Autor:
Kathleen N. Moore, Shannon R. Morris, Brian M. Slomovitz, David Mauro, Barbara Burtness, Christine H. Chung, Matthew L. Anderson, Ezra E.W. Cohen
Publikováno v:
Journal for Immunotherapy of Cancer
Meeting abstracts Approaches that target key HPV genes critical for cancer growth and metastasis may improve survival for individuals diagnosed with carcinomas of the uterine cervix or head and neck. ADXS11-001 is a live attenuated Listeria monocytog
Autor:
Deborah A. Smith, Christine Chen, Joanna Opalinska, Shannon R. Morris, Andrew Spencer, Sung-Soo Yoon, Simon J. Harrison, Rakesh Kumar, Richard A. Brigandi, Jennifer Gauvin
Publikováno v:
Blood. 124(14)
The PI3K/AKT pathway is constitutively active in hematologic malignancies, providing proliferative and antiapoptotic signals and possibly contributing to drug resistance. We conducted an open-label phase 1 study to evaluate the maximum tolerated dose
Evaluation Of Afuresertib, An Oral Pan-AKT Inhibitor, In Patients With Langerhans Cell Histiocytosis
Autor:
Beth Ann Reedy, Alison Portnoy, Mark L. Heaney, Robert Vassallo, Allen Oliff, Eric D. Jacobsen, Carlos Rodriguez-Galindo, Shannon R. Morris, Stephen Szabo, Ivan Borrello, Kenneth L. McClain, Ira J. Dunkel, James A. Whitlock, Deborah A. Smith, Robert J. Arceci, Sarah Vaseilbuh, Amy A. Murnane, Carl E. Allen, Bob Noble
Publikováno v:
Blood. 122:2907-2907
Background Langerhans cell histiocytosis (LCH) is a heterogeneous disease whose myriad manifestations result from accumulation of Langerhans cells in a variety of organs most commonly including skin, bone, central nervous system, liver, lymph nodes,
Autor:
Simon J. Harrison, Joanna Opalinska, Deborah A. Smith, Richard A. Brigandi, Steven J. Freedman, Shannon R. Morris, Sung-Soo Yoon, Allen Oliff, Andrew Spencer, Christine Chen
Publikováno v:
Blood. 118:1856-1856
Abstract 1856 Background: Despite significant progress in treatment, multiple myeloma (MM) remains an incurable disease. There is a well recognized need for new agents with novel mechanisms of action, which would complement currently available drugs.